Alzheimer's is the most common form of dementia, accounting for an estimated 60–70% of dementia cases worldwide. It is a progressive neurodegenerative condition in which abnormal protein deposits, amyloid plaques, and tau tangles accumulate in the brain, disrupting communication between nerve cells and eventually causing cell death.

The disease typically progresses through three stages, though the pace varies considerably between individuals:

Early stage: Mild memory lapses, difficulty finding words, subtle changes in mood or behaviour. Many people remain independent at this stage.

Middle stage: More pronounced memory loss affecting daily tasks, confusion about time and place, changes in personality, and increasing difficulty with activities such as cooking, driving, or managing finances.

Late stage: Significant loss of independence, difficulty with basic functions including swallowing and mobility, and near-total reliance on others for care.

Long-term consequences of Alzheimer's disease include:

• Progressive memory impairment affecting both short- and long-term recall
• Language difficulties, including word-finding problems and reduced speech
• Disorientation to time, place, and eventually familiar people
• Impaired judgement and executive function
• Behavioural changes, including agitation, anxiety, and depression
• Loss of the ability to perform activities of daily living independently
• In late stages, physical decline, including difficulties with swallowing and mobility

For families, the impact extends far beyond the patient. Caring for someone with Alzheimer's is one of the most demanding experiences a person can face, emotionally, physically, and financially.

Current standard-of-care treatments can slow symptom progression or manage associated behavioural changes. They cannot halt or reverse the underlying neurodegeneration.

This gap, the absence of treatments capable of addressing the neurological damage itself, has driven sustained scientific interest in regenerative approaches, including stem cell therapy.

Stem cell therapy takes a different angle on the disease. Rather than managing symptoms after the damage has occurred, the aim is to support the brain's own environment in ways that may slow further deterioration and, in some patients, contribute to functional improvement.

GS Medical Services coordinates treatment at specialist clinics in Germany that use mesenchymal stem cells (MSCs). These are adult stem cells with well-documented immunomodulatory and neuroprotective properties, and they have been studied across a range of neurodegenerative conditions.

The Science Behind Mesenchymal Stem Cells (MSCs)

MSCs do not simply replace lost neurons. Their primary mechanisms in Alzheimer's appear to be indirect; they alter the cellular environment in ways that may slow the disease process. Research suggests they can:

• Reduce neuroinflammation: Chronic inflammation in the brain is now understood to be a significant driver of Alzheimer's progression. MSCs can modulate the immune response, potentially reducing inflammatory damage to surviving neurons
• Secretes neuroprotective factors: MSCs release growth factors, including BDNF (brain-derived neurotrophic factor) and VEGF (vascular endothelial growth factor), that support the survival and function of existing brain cells
• Support amyloid clearance: Some research suggests MSCs may enhance the brain's mechanisms for clearing amyloid protein, one of the primary contributors to Alzheimer's pathology
• Promote angiogenesis: MSCs can stimulate the formation of new blood vessels, improving circulation in areas of the brain affected by the disease
• Encourage neuroplasticity: By creating a more favourable cellular environment, MSC therapy may support the brain's remaining capacity to form and strengthen neural connections

Potential Mechanisms of Action in Alzheimer's

Research into MSC therapy for Alzheimer's disease points to several areas where these cells may influence disease course:

• Paracrine signalling: MSCs act primarily through the signalling molecules they secrete, influencing the local cellular environment rather than directly replacing lost tissue. This paracrine effect is central to their potential benefit.
• Immunomodulation: In Alzheimer's, the brain's immune system (microglia) often becomes dysregulated, contributing to tissue damage. MSCs can dampen this overactive response, potentially reducing ongoing neurological harm.
• Synaptic support: Emerging evidence suggests MSC-derived factors may help preserve synaptic function, the connections between nerve cells that underpin memory and cognition.
• Reduction in tau pathology: Some preclinical studies have found that MSC treatment is associated with reduced tau tangle formation, though research in human patients is ongoing.

Important: Stem cell therapy for Alzheimer's disease is not a cure and does not reverse established neurological damage. Outcomes vary between individuals and depend on disease stage, overall health, and individual biological response. GS Medical Services coordinates access to this therapy based on a thorough, honest medical evaluation. We do not overstate what treatment can achieve.

Every patient referred through GS Medical Services receives a fully coordinated care journey. We manage the process from initial evaluation through to long-term follow-up, so that patients and families can focus on what matters.

Step 1: Comprehensive Medical Review and Eligibility Assessment

Your journey begins with a detailed evaluation to determine whether stem cell therapy is appropriate for your specific situation:

• Full neurological history, cognitive assessments, and functional review
• In-depth consultation with the medical team
• Honest assessment of candidacy, including a frank discussion of whether treatment is likely to be of benefit in your case
• Review of previous treatment history and response to existing medications

Step 2: Personalised Treatment Planning

If you are assessed as a suitable candidate, a treatment plan is developed based on your individual clinical profile:

• Protocol tailored to disease stage, cognitive and functional status, and overall health
• Clear explanation of the procedure, expected timeline, and realistic outcome expectations
• Transparent discussion of potential benefits, risks, and alternatives
• Comprehensive logistics support, including appointment coordination, documentation assistance, and accommodation guidance for international patients

Step 3: Cellular Therapy Procedure

Treatment is conducted at licensed clinics in Germany under the supervision of experienced, qualified physicians:

• Minimally invasive administration; typically intravenous (IV) or intrathecal injection, depending on the individual protocol
• On an outpatient basis, most patients return to their accommodation the same day
• Sterile clinical environment with full infection control protocols in place
• Physician-supervised throughout, with immediate post-treatment monitoring
• Local anaesthesia or sedation is used where appropriate

The procedure typically takes 2-4 hours, including preparation and post-procedure observation.

Step 4: Structured Follow-Up and Progress Monitoring

Your care does not end at the clinic door:

• Remote follow-up via secure telemedicine, no need for repeated international travel
• Progress evaluation using validated neurological and cognitive outcome measures
• Personalised rehabilitation guidance, including recommendations for cognitive stimulation and supportive therapies alongside cellular treatment
• Long-term monitoring to assess the durability of any treatment benefit
• Direct access to the medical team throughout your recovery

Throughout your recovery, the team remains accessible to provide support and respond to any questions or concerns.

Stem cell therapy is not appropriate for every patient with Alzheimer's disease. Based on current clinical evidence and the experience of the clinics we work with, individuals who may be considered for treatment typically include those with:

• A confirmed diagnosis of Alzheimer's disease (mild to moderate stage), supported by clinical assessment and appropriate imaging.
• Early-to-moderate cognitive and functional impairment, patients in the mild cognitive impairment (MCI) or mild-to-moderate Alzheimer's stage tend to have the most to gain, as there is more intact brain tissue to support and protect.
• Persistent symptoms despite a trial of standard pharmacological treatment.
• Generally stable overall health without significant active medical conditions that would complicate treatment.
• Realistic expectations and a clear understanding that outcomes vary between individuals.
• Family or carer support to assist with the treatment journey and follow-up rehabilitation.
• Commitment to ongoing cognitive and physical rehabilitation, alongside and following cellular therapy.

Patients in the early-to-moderate stage of Alzheimer's disease are typically considered the most suitable candidates for stem cell therapy. In late-stage disease, where significant neurological damage has already occurred, the potential for benefit is more limited, and we will be transparent about this during your evaluation.

Based on current clinical research and emerging patient outcomes, stem cell therapy for Alzheimer's may offer several potential benefits. Outcomes are not guaranteed and vary considerably between individuals.

• Cognitive stabilisation: Some patients report a slowing of cognitive decline following treatment, with relative preservation of memory and executive function over time
• Improved daily functioning: Enhanced capacity to perform activities of daily living and maintain a degree of independence
• Behavioural improvements: Reduction in agitation, anxiety, and associated behavioural symptoms of dementia
• Better quality of life: Patient and carer-reported improvements in overall wellbeing and quality of daily life
• Potential to slow progression: MSC therapy may help reduce the rate of neurological decline, particularly in earlier-stage disease
• Neuroinflammation reduction: Dampening the chronic inflammatory process that contributes to ongoing brain damage

Research published in peer-reviewed medical journals has reported improvements in cognitive function and quality-of-life measures following MSC therapy in patients with Alzheimer's disease. The field continues to develop, and GS Medical Services works with clinics that adhere to evidence-informed protocols.

As with any medical procedure, stem cell therapy carries potential risks. These will be discussed fully during your personalised consultation.

Common side effects (typically mild and temporary):

• Temporary fatigue or mild headache following treatment
• Low-grade fever for 24-48 hours post-procedure
• Mild discomfort or bruising at the injection or administration site
• Temporary fluctuation in neurological or cognitive symptoms in the first 1-2 weeks, which usually resolves on its own

Rare but serious complications:

• Infection at the injection or administration site; rare when appropriate clinical protocols are in place
• Allergic reaction to procedure components
• Thromboembolic events are very rare cases; screened for during pre-treatment assessment

Serious complications are uncommon when procedures are performed by qualified practitioners in appropriate clinical settings. All patients undergo comprehensive pre-procedure screening and post-procedure monitoring to minimise risk.

Post-treatment guidance: Following treatment, all patients receive clear written instructions covering activity recommendations, guidance on resuming cognitive rehabilitation therapies, warning signs that require prompt attention, and practical strategies to support the therapy's effectiveness through lifestyle and daily routine.

When exploring treatment options for Alzheimer’s disease, selecting a trusted medical coordination partner can make a meaningful difference in your care journey. GS Medical Services helps make this complex process more manageable by guiding families through every step of arranging medical care abroad. Our approach is built around the following principles:

• German Clinical Standards: We coordinate referrals to clinics operating under Germany's strict regulatory framework for cellular therapies, with physician-supervised, individually evaluated treatment protocols.
• Honest, Transparent Guidance: We provide clear, realistic information about candidacy, expected outcomes, and potential risks. We do not overstate what treatment can achieve, and we will tell you candidly if we do not think it is the right option for you.
• Personalised Coordination: No two patients are the same. We work through your specific clinical profile, disease stage, personal goals, and practical circumstances before making any referral.
• Dedicated Support for International Patients: From appointment scheduling and documentation to travel logistics and accommodation, we manage the practical details so that you and your family can focus on the person who matters most.
• Continuity of Care: Through secure telemedicine, your relationship with the treating medical team continues long after you leave Germany. Structured follow-up, monitoring, and guidance are built into the process from the start.

Compassionate & Expert Team: Our coordinators and medical advisors understand that Alzheimer's affects the whole family. We approach every consultation with that in mind.

If you or a family member is living with Alzheimer's disease and you are exploring whether stem cell therapy may be an appropriate option, the first step is a comprehensive medical evaluation. You may consult Dr. Med. Gerhard Siebenhüner for an expert assessment and personalised treatment guidance.

Your initial consultation will include:

• Confidential review of your medical records, imaging, and cognitive assessment history
• Honest assessment of whether you are a suitable candidate for cellular therapy
• Realistic discussion of potential benefits, risks, and expected outcomes for your specific case
• Clear explanation of the treatment process, timeline, and logistics
• Transparent pricing information with no hidden costs
• Opportunity to ask questions and address any concerns

There is no obligation to proceed with treatment following your consultation. Our goal is to provide you with the information and support you need to make an informed decision about your care.

How long does the stem cell therapy procedure for Alzheimer's disease take?
The procedure typically takes 2-4 hours, depending on the method of administration. Plan to spend around 4-6 hours at the clinic on the day, including preparation and post-procedure monitoring. Most patients return to their accommodation the same day.

How soon can daily activities be resumed after treatment?
Most patients can resume light daily activities within 2-3 days. Strenuous physical activity is typically avoided for 4-6 weeks. Cognitive stimulation activities and supportive therapies are encouraged from early in the recovery phase to complement the cellular treatment.

Is the stem cell therapy procedure for Alzheimer's disease painful?
The administration involves an injection or intravenous infusion, which may cause mild to moderate discomfort. Local anaesthesia or sedation is used where appropriate. Temporary fatigue or a mild headache in the first 24-48 hours is common and generally manageable.

Can patients in the later stages of Alzheimer's be considered for treatment?
Late-stage Alzheimer's patients are generally not considered suitable candidates, as the potential for meaningful benefit diminishes significantly when substantial neurological damage has already occurred. Patients in the mild-to-moderate stage tend to respond most favourably. Eligibility is assessed honestly and individually during consultation.

How much does stem cell therapy for Alzheimer's cost?
Costs vary according to the individual treatment plan and the number of sessions required. Detailed, transparent pricing is provided following your medical assessment. All pricing includes evaluation, the procedure, and structured follow-up care.

How is stem cell therapy regulated in Germany?
Stem cell therapies in Germany are subject to strict national regulation and must comply with established medical and safety standards. Treatment is conducted in licensed clinical facilities under the supervision of a qualified physician, following an individual medical evaluation. GS Medical Services coordinates referrals to clinics operating within this regulatory framework.

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Stem cell therapy outcomes vary considerably between individuals, and this treatment may not be suitable for everyone. Always consult a qualified medical professional before making decisions about your or a family member's health.